vs
Side-by-side financial comparison of Airsculpt Technologies, Inc. (AIRS) and Basel Medical Group Ltd (BMGL). Click either name above to swap in a different company.
Airsculpt Technologies, Inc. is a medical technology and aesthetic services provider specializing in its proprietary minimally invasive AirSculpt body contouring treatments. The company operates premium clinics across the United States, catering to consumers seeking precise fat removal and body shaping solutions with significantly shorter recovery times than traditional cosmetic procedures.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
Revenue
AIRS
BMGL
| Q4 25 | $33.4M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $44.0M | — | ||
| Q1 25 | $39.4M | — | ||
| Q4 24 | $39.2M | — | ||
| Q3 24 | $42.5M | — | ||
| Q2 24 | $51.0M | — | ||
| Q1 24 | $47.6M | — |
Net ProfitAIRSBMGL
| Q4 25 | $1.3M | — | ||
| Q3 25 | $-9.5M | — | ||
| Q2 25 | $-591.0K | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $-4.8M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-3.2M | — | ||
| Q1 24 | $6.0M | — |
Operating MarginAIRSBMGL
| Q4 25 | -3.0% | — | ||
| Q3 25 | -27.9% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | -4.0% | — | ||
| Q4 24 | -9.9% | — | ||
| Q3 24 | -8.7% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | 23.1% | — |
Net MarginAIRSBMGL
| Q4 25 | 3.8% | — | ||
| Q3 25 | -27.2% | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | -7.2% | — | ||
| Q4 24 | -12.3% | — | ||
| Q3 24 | -14.2% | — | ||
| Q2 24 | -6.3% | — | ||
| Q1 24 | 12.7% | — |
EPS (diluted)AIRSBMGL
| Q4 25 | $0.02 | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $-0.05 | — | ||
| Q4 24 | $-0.08 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q2 24 | $-0.06 | — | ||
| Q1 24 | $0.10 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
